Found: 113
Select item for more details and to access through your institution.
High-frequency episodic migraine: Time for its recognition as a migraine subtype?
- Published in:
- Cephalalgia, 2024, v. 44, n. 10, p. 1, doi. 10.1177/03331024241291578
- By:
- Publication type:
- Article
Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis.
- Published in:
- Cephalalgia, 2024, v. 44, n. 10, p. 1, doi. 10.1177/03331024241287224
- By:
- Publication type:
- Article
OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse.
- Published in:
- Frontiers in Neurology, 2018, p. N.PAG, doi. 10.3389/fneur.2018.00808
- By:
- Publication type:
- Article
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies.
- Published in:
- BMC Neurology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12883-022-02914-9
- By:
- Publication type:
- Article
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Have the IHS been followed? Laying the ground for the 4th edition.
- Published in:
- 2020
- By:
- Publication type:
- journal article
When does chronic migraine strike?
- Published in:
- 2020
- By:
- Publication type:
- Letter
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Board Walk - April 2019.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Headache, comorbidities and lifestyle in an adolescent population (The TEENs Study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comorbidity between idiopathic overactive bladder and chronic migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Replication study of previous migraine genome-wide association study findings in a Spanish sample of migraine with aura.
- Published in:
- Cephalalgia, 2015, v. 35, n. 9, p. 776, doi. 10.1177/0333102414557841
- By:
- Publication type:
- Article
A replication study of a GWAS finding in migraine does not identify association in a Spanish case-control sample.
- Published in:
- Cephalalgia, 2012, v. 32, n. 14, p. 1076, doi. 10.1177/0333102412457090
- By:
- Publication type:
- Article
Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1355877
- By:
- Publication type:
- Article
The influence of temporal unpredictability on the electrophysiological mechanisms of neural entrainment.
- Published in:
- Psychophysiology, 2022, v. 59, n. 11, p. 1, doi. 10.1111/psyp.14108
- By:
- Publication type:
- Article
Genome-wide association analysis identifies susceptibility loci for migraine without aura.
- Published in:
- Nature Genetics, 2012, v. 44, n. 7, p. 777, doi. 10.1038/ng.2307
- By:
- Publication type:
- Article
Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01783-6
- By:
- Publication type:
- Article
Headache in COVID-19 and Long COVID: to Know Facts for Clinical Practice.
- Published in:
- Current Neurology & Neuroscience Reports, 2023, v. 23, n. 10, p. 551, doi. 10.1007/s11910-023-01296-w
- By:
- Publication type:
- Article
Reversible white matter alterations in encephalopathy associated with autoimmune thyroid disease.
- Published in:
- Journal of Neurology, 2002, v. 249, n. 8, p. 1063, doi. 10.1007/s00415-002-0788-z
- By:
- Publication type:
- Article
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. e2215499, doi. 10.1001/jamanetworkopen.2022.15499
- By:
- Publication type:
- Article
High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A protocol for a systematic review of controlled trials.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0251528
- By:
- Publication type:
- Article
Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01772-9
- By:
- Publication type:
- Article
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01747-w
- By:
- Publication type:
- Article
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01727-0
- By:
- Publication type:
- Article
Mode and site of action of therapies targeting CGRP signaling.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01644-8
- By:
- Publication type:
- Article
Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, p. 1, doi. 10.1186/s10194-023-01655-5
- By:
- Publication type:
- Article
Exploring sensory sensitivity, cortical excitability, and habituation in episodic migraine, as a function of age and disease severity, using the pattern-reversal task.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01618-w
- By:
- Publication type:
- Article
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01502-z
- By:
- Publication type:
- Article
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 5, p. 461, doi. 10.1001/jamaneurol.2024.0368
- By:
- Publication type:
- Article
Are we closer to achieving precision medicine for migraine treatment? A narrative review.
- Published in:
- Cephalalgia, 2024, v. 44, n. 9, p. 1, doi. 10.1177/03331024241281518
- By:
- Publication type:
- Article
Case series on monoclonal antibodies targeting calcitonin gene-related peptide in migraine patients during pregnancy: Enhancing safety data.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action.
- Published in:
- Cephalalgia, 2024, v. 44, n. 8, p. 1, doi. 10.1177/03331024241267309
- By:
- Publication type:
- Article
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury.
- Published in:
- Cephalalgia, 2024, v. 44, n. 3, p. 1, doi. 10.1177/03331024241234068
- By:
- Publication type:
- Article
Quantifying sensory thresholds along the migraine cycle: An exploratory longitudinal study.
- Published in:
- Cephalalgia, 2024, v. 44, n. 2, p. 1, doi. 10.1177/03331024241230279
- By:
- Publication type:
- Article
International Classification of Headache Disorders-4 – Work in Progress 1.
- Published in:
- Cephalalgia, 2024, v. 44, n. 2, p. 1, doi. 10.1177/03331024241233937
- By:
- Publication type:
- Article
Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies.
- Published in:
- Cephalalgia, 2024, v. 44, n. 2, p. 1, doi. 10.1177/03331024231222923
- By:
- Publication type:
- Article
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 11, p. 1, doi. 10.1177/03331024231214987
- By:
- Publication type:
- Article
Epidemiology, burden and clinical spectrum of cluster headache: a global update.
- Published in:
- Cephalalgia, 2023, v. 43, n. 9, p. 1, doi. 10.1177/03331024231201577
- By:
- Publication type:
- Article
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 5, p. 1, doi. 10.1177/03331024231170807
- By:
- Publication type:
- Article
Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension.
- Published in:
- Cephalalgia, 2023, v. 43, n. 8, p. 1, doi. 10.1177/03331024231197118
- By:
- Publication type:
- Article
Harassment in the headache field: a global web-based cross-sectional survey.
- Published in:
- Cephalalgia, 2023, v. 43, n. 8, p. 1, doi. 10.1177/03331024231193099
- By:
- Publication type:
- Article
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 8, p. 1, doi. 10.1177/03331024231177636
- By:
- Publication type:
- Article
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials.
- Published in:
- Cephalalgia, 2023, v. 43, n. 4, p. 1, doi. 10.1177/03331024231159366
- By:
- Publication type:
- Article
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221146317
- By:
- Publication type:
- Article
The impact of epigenetic mechanisms in migraine: Current knowledge and future directions.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221145916
- By:
- Publication type:
- Article
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review.
- Published in:
- Cephalalgia, 2023, v. 43, n. 1, p. 1, doi. 10.1177/03331024221131337
- By:
- Publication type:
- Article
Perceived barriers to career progression in the headache field: A global web-based cross-sectional survey.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Avoidance behaviour modulates but does not condition phonophobia in migraine.
- Published in:
- Cephalalgia, 2022, v. 42, n. 13, p. 1305, doi. 10.1177/03331024221111772
- By:
- Publication type:
- Article